Cocaine Intoxication Treatment Market to Hit US$ 15.75 Million by 2031| Exclusive Report by Growth Plus Reports

Newark, New Castle, USA, June 26, 2023 (GLOBE NEWSWIRE) — The market analysis of the global cocaine intoxication treatment market was conducted by Growth Plus Reports in 2022 and valued at US$ 9.3 million. The market is expected to hit a revenue CAGR of 5.9% to reach US$ 15.75 million by 2031.

Key Takeaways: 

• The cutting-edge treatment methods and the application of cutting-edge technologies in treating cocaine intoxication are receiving more and more attention. 
• Recent advances in neurology, pharmacology, and digital pharmaceuticals have opened up new possibilities for developing targeted and customized therapeutics. 
• New technologies, including neurofeedback, virtual reality, and smartphone applications, are discussed in the paper as potential aids in relapse prevention and addiction treatment.

Get a Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/cocaine-intoxication-treatment-market/8335

                                   Cocaine Intoxication Treatment Market Scope

The market for therapies for cocaine intoxication is expected to have significant worldwide revenue growth due to the rising prevalence of cocaine addiction globally. Strong stimulant cocaine has significant health risks, including addiction, heart and circulatory problems, brain problems, and other effects that might be lethal. As a result, the need for effective cocaine intoxication treatment options has sharply increased.

Recent Development in the Cocaine Intoxication Treatment Market: 

• In August 2022, Tonix Pharmaceuticals Holding Inc. received financing through a Cooperation Agreement from the National Institute on Drug Addiction to help create TNX-1300, a recombinant enzyme for treating cocaine intoxication. In earlier clinical studies, it was shown that the drug TNX-1300 might help cocaine addicts recover physiologically from an intravenous cocaine challenge. The grant funded the ongoing research of TNX-1300 as a treatment for cocaine overdose that poses a life-threatening risk.

Competitive Landscape:

The research also provides a comprehensive overview of the major players active in the market for treatments for cocaine intoxication. It includes information on their product lines, R&D pursuits, tactical plans, and partnerships. The section on the market’s competitive dynamics and leading competitors’ tactics for gaining a competitive edge in the sector are highlighted in the section on the competitive landscape.

The market players operating in the global market for cocaine intoxication treatment include: 

• Manus Aktteva Biopharma LLP
• Pfizer Inc.
• Anant Pharmaceuticals Pvt. Ltd
• GlaxoSmithKline Plc.
• Bristol Myers Squibb Company
• Novartis AG

Request for Customization – https://www.growthplusreports.com/inquiry/customization/cocaine-intoxication-treatment-market/8335

Market Segmentation: 

• The global therapy for cocaine intoxication has been examined from four angles: drug class, administration route, distribution route, and area.
• The market for treating cocaine intoxication may be further segmented into phentolamine, lorazepam, diazepam, verapamil, and morphine based on the drug class. According to estimates, lorazepam accounts for a sizable portion of sales.
• The market for treating cocaine intoxication may be further segmented based on the mode of delivery into oral, inhalation, intravenous, and nasal. Most income generated by cocaine intoxication treatment medications is generated through oral administration.
• The market for treating cocaine intoxication may be further segmented into hospital pharmacies, retail pharmacies, and internet pharmacies based on the distribution route. In 2022, hospital pharmacies registered the greatest revenue share worldwide.

The research also highlights significant market prospects in various parts of the world. It examines the market potential in North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa by considering governmental efforts, healthcare infrastructure, and reimbursement policies. The regional analysis makes understanding the development prospects and investment possibilities in each region easier for stakeholders and investors.

Table of Content

1. INTRODUCTION
   1. Market Ecosystem 
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions       
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022)
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints
   3. Opportunities
5. GLOBAL COCAINE INTOXICATION TREATMENT MARKET- ANALYSIS & FORECAST, BY DRUG CLASS
   1. Phentolamine
   2. Lorazepam
   3. Diazepam
   4. Verapamil
   5. Morphine
6. GLOBAL COCAINE INTOXICATION TREATMENT MARKET- ANALYSIS & FORECAST, BY ROUTE OF ADMINISTRATION
   1. Oral
   2. Inhalation
   3. Intravenous
   4. Nasal
7. GLOBAL COCAINE INTOXICATION TREATMENT MARKET- ANALYSIS & FORECAST, BY DISTRIBUTION CHANNEL
   1. Hospital Pharmacies
   2. Retail Pharmacies
   3. Online Pharmacies

COCAINE INTOXICATION TREATMENT MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8335

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market.

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse more latest healthcare reports:

Postoperative Pain Medication Market by Drug Class (NSAIDS, Opioids), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Mast Cell Stabilizers Market by Type (Mastocytosis, Seasonal Allergic Rhinitis, and Perennial Allergic Conjunctivitis), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook and Forecast 2023-2031

COMT Inhibitors Market by Drugs (Entacapone, Tolcapone), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Neurofibromatosis Market by Type (NF1, NF2), Drug Class (Antihistamines, Antineoplastic Agents), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Synthetic Ovulation Stimulants Market by Drug Class (Clomiphene Citrate (CC), Aromatase Inhibitors, GnRH Analogs), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook and Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.